InvestorsObserver
×
News Home

Where Does Wall Street Think Arcturus Therapeutics Holdings Inc (ARCT) Stock Will Go?

Thursday, August 18, 2022 12:47 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Arcturus Therapeutics Holdings Inc (ARCT) Stock Will Go?

Wall Street is positive on Arcturus Therapeutics Holdings Inc (ARCT). On average, analysts give the stock a Buy rating. The average price target is $47.7, which means analysts expect the stock to gain by 168.43% over the next twelve months. That average ranking earns the stock an Analyst Rating of 13, which is better than 13% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3.2
Wall Street analysts are rating ARCT a Buy today. Find out what this means to you and get the rest of the rankings on ARCT!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?

Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $17.77 as of 12:47 PM on Thursday, Aug 18, a decline of -$1.68, or -8.64% from the previous closing price of $19.45. The stock has traded between $17.25 and $19.50 so far today. Volume today is less active than usual. So far 181,816 shares have traded compared to average volume of 445,483 shares. Click Here to get the full Stock Report for Arcturus Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App